Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases.The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for asthma and chronic obstructive pulmonary disease, among others.
It utilizes technologies such as low-alcohol formulation, platform; hydrofluoroalkane, metered dose inhaler and dry powder inhaler platforms to develop drugs, among others.Intech Biopharm offers pipeline products such as SYN006 that is being developed to relieve the bronchoconstriction symptoms during asthma attacks; SYN007 for COPD; and SYN010 for asthma, COPD, and others.
The company also intends to develop drugs for treating cancers and other diseases affecting people globally. Intech Biopharm is headquartered in Taipei City, Taiwan.
Intech Biopharm Ltd (6461) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Blood Purification Equipment - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Blood Purification Equipment - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Blood Purification Equipment pipeline products with comparative...
Process automation and instrumentation market to exhibit significant growth potential from 2020 to 2025 The process automation and instrumentation market is expected to be valued at USD 67.4billion in 2020 and is projected to reach USD 76.8 billion by 2025, at a CAGR of 2.6%. Increasing importance of reduced operating costs...
The global biopolymer packaging market was valued at US$ 7,872.54 million in 2018 and is projected to reach US$ 37,465.07 million by2027; it is expected to grow at a CAGR of 19.1% from 2019 to 2027. Bio based polymers are considered to be an effective alternative to the conventional polymers and are being increasingly used in packaging...
Online Pharmacy Market Research Report by Type (Non-prescription and Prescription), by Distribution Channel (App only and Online store) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Online Pharmacy Market is expected to grow from USD 35,239.48 Million in 2019 to USD 72,226.68 Million by the end...
Pharmaceutical Contract Manufacturing Market Research Report by Type of Contract Manufacturing (API or Bulk Drug Manufacturing and Final Dosage Form) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Pharmaceutical Contract Manufacturing Market is expected to grow from USD 87,209.52 Million in 2019...
The companion diagnostics market is estimated to grow at a CAGR of 12.9% The companion diagnostics market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12.9%. The growth of the companion diagnostics industry is tied primarily to its various advantages, the growing need for targeted...
134 pages •
By Global Industry Analysts
• Jul 2020
Global Pharmaceutical Contract Packaging Market to Reach $17.1 Billion by 2027 Amid the COVID-19 crisis, the global market for Pharmaceutical Contract Packaging estimated at US$11.3 Billion in the year 2020, is projected to reach a revised size of US$17.1 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027....